QTc

1. Dapagliflozin decreases QTc in humans (-10.1 ms, p < .001).

   Human trialtype 2 diabetes mellitus3 monthsn = 700

   Effect of dapagliflozin on electrocardiographic arrhythmic markers in patients with type 2 diabetes mellitus · British journal of clinical pharmacology · 13 Sep 2026

Dapagliflozin →

1. SGLT2 inhibitors decrease QTc in humans (MD -4.9 ms).

   Human trialn = 5,022

   Effect of sodium-glucose cotransporter-2 inhibitors on electrocardiographic markers of ventricular repolarization: A systematic review and meta-analysis · American heart journal plus : cardiology research and practice · 9 Sep 2026

SGLT2 inhibitors →